bisoprolol has been researched along with Cardiometabolic Syndrome in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty patients (18 women and 12 men) with metabolic syndrome and mild arterial hypertension took bisoprolol alone in a dose 5-10 mg/day, and fifteen patients received combined therapy (bisoprolol and actovegin) for 12 weeks." | 3.73 | [Primary prophylaxis of cerebrovascular complications in patients with metabolic syndrome]. ( Chazova, IE; Gornostaev, VV; Mychka, VB; Sergienko, VB, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mychka, VB | 1 |
| Chazova, IE | 1 |
| Gornostaev, VV | 1 |
| Sergienko, VB | 1 |
1 other study available for bisoprolol and Cardiometabolic Syndrome
| Article | Year |
|---|---|
[Primary prophylaxis of cerebrovascular complications in patients with metabolic syndrome].
Topics: Adult; Antihypertensive Agents; Bisoprolol; Brain; Carbohydrate Metabolism; Cerebrovascular Circulat | 2005 |